论文部分内容阅读
应用中医中药治疗肝硬化腹水的药物，进行动物实验。通过扫描电镜和计算机联机的图像处理系统，对药物的腹膜孔调控和促腹水转归作用，作了观察和定量分析。结果发现，丹参和泽泻均有显著开大腹膜孔的功能（Ｐ＜０．０５），并使腹膜孔开放数目增加，分布密度明显增高（Ｐ＜０．０５）。茯苓和茯苓皮对腹膜孔的调控作用均不明显（Ｐ＞０．０５）。本文结果首次证实丹参和泽泻对腹膜孔有调控作用。根据腹膜孔对腹水的转归机制，丹参和泽泻有较强的腹水转归作用
The use of traditional Chinese medicine for the treatment of liver cirrhosis ascites, animal experiments. Through the scanning electron microscope and computer on-line image processing system, the peritoneal pore regulation of the drug and the promotion of ascitic fluid outcome were observed and quantitatively analyzed. The results showed that both Salvia miltiorrhiza and Alisma showed significant peritoneal opening (P<0.05), increased peritoneal opening and increased distribution density (P<0.05). The regurgitation of peritoneal opening was not significant in both lice and lice (P>0.05). This article confirmed for the first time that Danshen and Alisma have regulatory effects on peritoneal holes. According to the mechanism of peritoneal orifice on ascites, Salvia miltiorrhiza and Alisma have strong ascites